US Stocks
/
Novavax, Inc. Share Price

Novavax, Inc. Share Price

NASDAQ: NVAX | Small Cap
$10.10
+$0.11 (1.05%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Novavax, Inc. Stock Performance

Open
$9.97
Prev. Close
$9.99
Circuit Range
N/A
Day Range
$9.77 - $10.14
Year Range
$6.21 - $11.96
Volume
2,43,234
Average Traded
$9.99

Novavax, Inc. Share Price Today

As of 19 September 2026, Novavax, Inc.'s share price is $10.10. The stock opened at $9.97, compared to its previous close of $9.99. During today's trading session, Novavax, Inc.'s share price traded between $9.77 and $10.14, with an average price of $9.96. Over the past 52 weeks, the stock has recorded a high of $11.96 and a low of $6.21. In terms of performance, Novavax, Inc.'s share price has risen by 23.93% over the last six months and is up 16.63% on a year-on-year basis.

Novavax, Inc. Share Price Chart

$9.77$10.14
L
Show Current Price
H

Novavax, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.64B
PE Ratio (TTM)
3.71
Dividend Yield
N/A
EPS (TTM)
$2.72
Revenue (TTM)
$1.12B
Return On Equity (TTM)
-344.65%
Profit Margin
39.19%
Debt to Equity
-3.60
Quarterly Earnings Growth YoY
-66.84%

Novavax, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/A$415.48M$84.51M$666.65M$239.24M$70.44M
Net Profit-$147.55M$162.38M-$121.30M$518.65M$106.51M-$202.38M
Net Profit MarginN/A39.08%-143.53%77.80%44.52%-287.29%
Income ChangeN/A210.05%-174.70%527.57%-79.46%-290.01%

Novavax, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
Revenue-$2.83B$1.98B$983.71M$682.16M$1.12B
Net Profit-$1.74B-$657.94M-$545.06M-$187.50M$440.30M
Net Profit Margin61.55%-33.20%-55.41%-27.49%39.19%
Income ChangeN/A62.27%17.16%65.60%334.83%

About Novavax, Inc.

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Novavax, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$9.20
$10.12
+11.64%
Aug 2026
$7.35
$9.06
+23.94%
Jul 2026
$9.37
$7.31
-22.40%
Jun 2026
$10.82
$9.42
-14.05%
May 2026
$7.88
$10.96
+38.38%
Apr 2026
$8.22
$7.92
-2.82%
Mar 2026
$9.76
$8.15
-19.63%
Feb 2026
$8.65
$10.14
+14.58%
Jan 2026
$6.79
$8.85
+31.50%
Dec 2025
$6.83
$6.73
-4.54%
Nov 2025
$8.31
$7.05
-16.17%
Oct 2025
$8.74
$8.41
-2.89%

NVAX Share Price FAQs

What is Novavax, Inc. share price today?

chevron-up
Novavax, Inc. share price today is $10.10 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Novavax, Inc. stock?

chevron-up
The 52 week high of Novavax, Inc. stock is $11.96, while the 52 week low is $6.21 as of 19 Sep '26.

What is NVAX's market capitalisation today?

chevron-up
NVAX market capitalisation is $1.64B as of September 19, 2026, at 6:40 am IST.

What is NVAX's net income for the last quarter?

chevron-up
NVAX's net income for the last quarter is -0.20B USD.

What is the 5 year returns of NVAX?

chevron-up
The 5 year returns of NVAX is -95.13% as on 19 Sep '26.

What is the high & low stock price of NVAX today?

chevron-up
NVAX stock price hit a high of $10.14 and low of $9.77 as of 19 Sep '26.

Can I buy NVAX shares in India?

chevron-up
Yes. You can buy NVAX in India by opening an international trading account.